Chengdu Kanghua Biological Products Co., Ltd. (300841.SZ)

60.80 +1.20 (+2.01%) At close: 03:04PM CST

Chengdu Kanghua Biological Products Co., Ltd.

No. 182, Beijing Road
Eco & Tech Dev Zn
Chengdu 610100
China
86 28 8484 6555
https://www.kangh.com

Sector(s): Healthcare
Industry: Biotechnology
Full-time employees: 672

Key executives

Name	Title	Pay	Exercised	Year born
Mr. Zhen Tao Wang	Chairman & GM	N/A	N/A	1965
Mr. Wennian Wu	Deputy GM & CFO	N/A	N/A	1983
Mr. Wenli Hou	Deputy GM & Director	N/A	N/A	1984
Mr. Hao Lu	Deputy GM & Secretary of the Board	N/A	N/A	1986
Mr. Huaigong Chen	Deputy GM & Quality Manager	N/A	N/A	1973
Mr. Wanfeng Sun	Deputy General Manager	N/A	N/A	1980

Amounts are as of , and compensation values are for the last fiscal year ending on that date. Pay includes salary, bonuses, etc. Exercised is the value of options exercised during the fiscal year. Currency in CNY.

Description

Chengdu Kanghua Biological Products Co., Ltd. engages in the research, development, production, sale, and technical service of biological products in China. It offers group ACYW135 meningococcal polysaccharide vaccines; and freeze-dried human diploid cell rabies vaccines. The company also develops seasonal influenza vaccines without preservatives, which completed phase III clinical trials. In addition, it exports its products. The company was founded in 2004 and is based in Chengdu, China.

Corporate governance

Chengdu Kanghua Biological Products Co., Ltd.’s ISS governance QualityScore as of N/A is N/A. The pillar scores are Audit: N/A; Board: N/A; Shareholder rights: N/A; Compensation: N/A.

Corporate governance scores courtesy of Institutional Shareholder Services (ISS). Scores indicate decile rank relative to index or region. A decile score of 1 indicates lower governance risk, while 10 indicates higher governance risk.